Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Clinical predictors for survival and treatment outcome of high-grade glioma in Prasat Neurological Institute.

Noiphithak R, Veerasarn K.

Asian J Neurosurg. 2017 Jan-Mar;12(1):28-33. doi: 10.4103/1793-5482.148791.

2.

Investigating the impact of headaches on the quality of life of patients with glioblastoma multiforme: a qualitative study.

Bennett SR, Cruickshank G, Lindenmeyer A, Morris SR.

BMJ Open. 2016 Nov 16;6(11):e011616. doi: 10.1136/bmjopen-2016-011616.

3.

Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial.

Brown PD, Jaeckle K, Ballman KV, Farace E, Cerhan JH, Anderson SK, Carrero XW, Barker FG 2nd, Deming R, Burri SH, Ménard C, Chung C, Stieber VW, Pollock BE, Galanis E, Buckner JC, Asher AL.

JAMA. 2016 Jul 26;316(4):401-9. doi: 10.1001/jama.2016.9839.

4.

Sleep-wake disturbance in patients with brain tumors.

Armstrong TS, Shade MY, Breton G, Gilbert MR, Mahajan A, Scheurer ME, Vera E, Berger AM.

Neuro Oncol. 2017 Mar 1;19(3):323-335. doi: 10.1093/neuonc/now119.

PMID:
27286798
5.

Clinical outcome assessment in malignant glioma trials: measuring signs, symptoms, and functional limitations.

Blakeley JO, Coons SJ, Corboy JR, Kline Leidy N, Mendoza TR, Wefel JS.

Neuro Oncol. 2016 Mar;18 Suppl 2:ii13-ii20. doi: 10.1093/neuonc/nov291. Review.

6.

Determining priority signs and symptoms for use as clinical outcomes assessments in trials including patients with malignant gliomas: Panel 1 Report.

Armstrong TS, Bishof AM, Brown PD, Klein M, Taphoorn MJ, Theodore-Oklota C.

Neuro Oncol. 2016 Mar;18 Suppl 2:ii1-ii12. doi: 10.1093/neuonc/nov267. Review.

7.

Quality of Life and Patterns of Use of Complementary and Alternative Medicines Among Glioma Patients.

Mobed K, Liu R, Stewart S, Wrensch M, McCoy L, Rice T, Prados M, Chang S.

J Support Oncol. 2009 Nov-Dec;7(6):W23-W31.

8.

Experiencing brain cancer: what physicians should know about patients.

Lucchiari C, Botturi A, Manzini L, Masiero M, Pravettoni G.

Ecancermedicalscience. 2015 Nov 12;9:591. doi: 10.3332/ecancer.2015.591. eCollection 2015.

9.

Concordance of patient and caregiver reports in evaluating quality of life in patients with malignant gliomas and an assessment of caregiver burden.

Jacobs DI, Kumthekar P, Stell BV, Grimm SA, Rademaker AW, Rice L, Chandler JP, Muro K, Marymont M, Helenowski IB, Wagner LI, Raizer JJ.

Neurooncol Pract. 2014 Jun;1(2):47-54. Epub 2014 May 5.

10.

Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigue.

Page BR, Shaw EG, Lu L, Bryant D, Grisell D, Lesser GJ, Monitto DC, Naughton MJ, Rapp SR, Savona SR, Shah S, Case D, Chan MD.

Neuro Oncol. 2015 Oct;17(10):1393-401. doi: 10.1093/neuonc/nov084. Epub 2015 May 12.

11.

The potential role of exercise in neuro-oncology.

Cormie P, Nowak AK, Chambers SK, Galvão DA, Newton RU.

Front Oncol. 2015 Apr 8;5:85. doi: 10.3389/fonc.2015.00085. eCollection 2015. Review.

12.

Palliative care and quality of life in neuro-oncology.

Mummudi N, Jalali R.

F1000Prime Rep. 2014 Aug 1;6:71. doi: 10.12703/P6-71. eCollection 2014. Review.

13.

Impact of health-related quality of life and fatigue on survival of recurrent high-grade glioma patients.

Peters KB, West MJ, Hornsby WE, Waner E, Coan AD, McSherry F, Herndon JE 2nd, Friedman HS, Desjardins A, Jones LW.

J Neurooncol. 2014 Dec;120(3):499-506. doi: 10.1007/s11060-014-1574-3. Epub 2014 Aug 13.

14.

Prevalence and predictors of fatigue in glioblastoma: a prospective study.

Valko PO, Siddique A, Linsenmeier C, Zaugg K, Held U, Hofer S.

Neuro Oncol. 2015 Feb;17(2):274-81. doi: 10.1093/neuonc/nou127. Epub 2014 Jul 8.

15.

Assessment of clinical and nonclinical characteristics associated with health-related quality of life in patients with high-grade gliomas: a feasibility study.

Porter KR, Menon U, Vick NA, Villano JL, Berbaum ML, Davis FG.

Support Care Cancer. 2014 May;22(5):1349-62. doi: 10.1007/s00520-013-2093-z. Epub 2014 Jan 3.

16.

Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma.

Chaichana KL, Jusue-Torres I, Navarro-Ramirez R, Raza SM, Pascual-Gallego M, Ibrahim A, Hernandez-Hermann M, Gomez L, Ye X, Weingart JD, Olivi A, Blakeley J, Gallia GL, Lim M, Brem H, Quinones-Hinojosa A.

Neuro Oncol. 2014 Jan;16(1):113-22. doi: 10.1093/neuonc/not137. Epub 2013 Nov 26.

17.

Using a psychosocial registry as a data source for nurses.

Kelley CG, Lipson AR, Daly B, Douglas SL.

Clin J Oncol Nurs. 2013 Aug 1;17(4):444-6. doi: 10.1188/13.CJON.444-446.

18.

A longitudinal, qualitative and quantitative exploration of daily life and need for rehabilitation among patients with high-grade gliomas and their caregivers.

Piil K, Jarden M, Jakobsen J, Christensen KB, Juhler M.

BMJ Open. 2013 Jul 11;3(7). pii: e003183. doi: 10.1136/bmjopen-2013-003183. Print 2013.

19.

Neurocognitive functioning in adult WHO grade II gliomas: impact of old and new treatment modalities.

Klein M.

Neuro Oncol. 2012 Sep;14 Suppl 4:iv17-24. doi: 10.1093/neuonc/nos161. Review.

20.

Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome.

Deschler B, Ihorst G, Platzbecker U, Germing U, März E, de Figuerido M, Fritzsche K, Haas P, Salih HR, Giagounidis A, Selleslag D, Labar B, de Witte T, Wijermans P, Lübbert M.

Haematologica. 2013 Feb;98(2):208-16. doi: 10.3324/haematol.2012.067892. Epub 2012 Aug 8.

Supplemental Content

Support Center